Damian Lismore

Mr Lismore brings extensive commercial, international, and listed company expertise to the Board, with a proven track record across the ASX and NASDAQ. His industry background spans growth sectors, including healthcare, technology, biotechnology, and medical devices. He held senior leadership roles within innovation-driven organisations, successfully guiding capital-raising initiatives, corporate transactions, and technology commercialisation. He is Chair of Risk Committee.